Literature DB >> 4038712

Diurnal hypersecretion of growth hormone in depression.

J Mendlewicz, P Linkowski, M Kerkhofs, D Desmedt, J Golstein, G Copinschi, E Van Cauter.   

Abstract

A 24-h profile of plasma GH concentrations was obtained together with polygraphic recordings of sleep in 16 men suffering from a major depressive disorder (8 unipolar and 8 bipolar) and in 8 age- and sex-matched normal men. None of the patients had any physical illness. All were studied after a drug-free period of at least 15 days. Blood was sampled every 15 min. The amount of GH released in every significant secretory spike was estimated using a computer program. Both unipolar and bipolar depressed patients secreted more GH than normal men (mean +/- SD, 441 +/- 189 micrograms/24 h for unipolar depressed men; 357 +/- 143 micrograms/24 h for bipolar depressed men vs. 172 +/- 101 micrograms/24 h for normal men (P less than 0.01). This hypersecretion occurred during waking hours rather than during sleep. The increase in daytime GH release was more marked in unipolar depressed patients. During sleep, depressed patients and normal men secreted similar amounts of GH despite an overall reduction in slow wave stages in depressed patients. An early sleep GH increase was found in all but one of the normal men, but was absent in seven of the eight unipolar depressed patients, who had, instead, a presleep increase in between 2100-0000 h. No consistent disturbance of the temporal association between sleep onset and GH secretion was found in bipolar depressed patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4038712     DOI: 10.1210/jcem-60-3-505

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

Review 1.  Melatonin, circadian rhythms, and the clock genes in bipolar disorder.

Authors:  Sara Dallaspezia; Francesco Benedetti
Journal:  Curr Psychiatry Rep       Date:  2009-12       Impact factor: 5.285

Review 2.  The neuroendocrine approach to psychiatric disorders: a critical appraisal.

Authors:  E E Müller
Journal:  J Neural Transm Gen Sect       Date:  1990

Review 3.  Multifactorial control of the 24-hour secretory profiles of pituitary hormones.

Authors:  E Van Cauter; S Refetoff
Journal:  J Endocrinol Invest       Date:  1985-08       Impact factor: 4.256

4.  Arginine induced growth hormone (hGH) response and paradoxical hGH secretion stimulated by TRH in diabetes mellitus.

Authors:  G Winkler; L Gerö; T Halmos; A Grósz; G Gefferth; P Varga; G Tamás
Journal:  Acta Diabetol Lat       Date:  1987 Apr-Jun

Review 5.  Chronobiology of bipolar disorder: therapeutic implication.

Authors:  Sara Dallaspezia; Francesco Benedetti
Journal:  Curr Psychiatry Rep       Date:  2015-08       Impact factor: 5.285

Review 6.  Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications.

Authors:  E E Müller; M Rolla; E Ghigo; D Belliti; E Arvat; A Andreoni; A Torsello; V Locatelli; F Camanni
Journal:  Drugs       Date:  1995-11       Impact factor: 9.546

7.  Growth hormone and cortisol secretion in relation to sleep and wakefulness.

Authors:  J R Davidson; H Moldofsky; F A Lue
Journal:  J Psychiatry Neurosci       Date:  1991-07       Impact factor: 6.186

Review 8.  Psychoneuroendocrine research in depression. II. Hormonal responses to releasing hormones as a probe for hypothalamic-pituitary-endorgan dysfunction.

Authors:  K P Lesch; R Rupprecht
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

9.  Diurnal rhythm in serum osteocalcin: relation with sleep, growth hormone, and PTH(1-84).

Authors:  H K Nielsen; K Brixen; M Kassem; S E Christensen; L Mosekilde
Journal:  Calcif Tissue Int       Date:  1991-12       Impact factor: 4.333

10.  Manipulating the sleep-wake cycle and circadian rhythms to improve clinical management of major depression.

Authors:  Ian B Hickie; Sharon L Naismith; Rébecca Robillard; Elizabeth M Scott; Daniel F Hermens
Journal:  BMC Med       Date:  2013-03-22       Impact factor: 8.775

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.